1 min read

FinTech in Texas

Molecule was highlighted as one of eight growth and late-stage companies leading the charge in the Texas FinTech sector.

Molecule was recently featured in TEN Capital Group's Where is Fintech in Texas?

Molecule was highlighted as one of eight growth and late-stage companies leading the charge in the Texas FinTech sector. As the article states, "Texas FinTech is likely to see a boom in investment and strong M&A activity as new means of transacting business and changing consumer behaviors transform the financial services, payments, and insurance industry as a whole." The article goes on to state that "this funding activity will involve disruptive technologies that we are only beginning to see the power of." Humbling? Absolutely. Redefining energy fintech software? You bet. And we like to think that we're just getting started.

At Molecule, we once defined ourselves as an energy risk platform designed to serve hedge funds, physical trading companies, and some of the largest financial institutions in the world. In our current conversations with prospects, our team realizes how quickly we are redefining the traditional ETRM space. As a next-generation cloud platform, we are deploying technology and operating in a way that we (hope) redefines the way enterprise software is made -- one monthly fee, no implementation fees, and product enhancements provided (on schedule) at no additional charge.

While we may have struggled with our energy identity in the past, our product blurs the lines between disruptive fintech software, a next-gen informatics platform, and a best-in-class risk reporting capability unlike anything else in the financial portfolio management (and energy) world.

We live and breathe elegant technology, design, ease of use, with the ultimate goal of zero care and feeding. Thanks to TEN Capital for the special acknowledgement in the Texas FinTech market. The inspiration and validation of our customer-first approach keeps us inspired to lead the charge from the head of the pack.

What Will I Save by Using Molecule

Selling Against a Fallacy in ETRM/CTRM Software

5 Problems with ETRM